Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
170 |
|
| Actual shortage: | 6 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 5 (3%) | |
| Resolved: | 158 (93%) | |
Discontinuation Reports |
54 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 52 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (15%) |
|
Overdue reports |
5 (56%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2017-11-28 | 2018-01-08 | 30982 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2018-10-17 | 2018-12-18 | 64629 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-03-20 | 2019-07-23 | 79017 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-11-08 | 2019-12-19 | 98249 |
| TEGRETOL | 200MG | TABLET | Resolved | 2019-12-19 | 2020-04-17 | 101771 |
| TEGRETOL CR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-05-07 | 2025-03-12 | 227205 |
| TEGRETOL CR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-08-27 | 2024-12-09 | 235978 |
| TEGRETOL CR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-05-07 | 2025-03-12 | 227209 |
| TEGRETOL CR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-10-01 | 2024-11-02 | 239094 |
| TEGRETOL CR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-12-09 | 2025-02-05 | 245118 |
| TEGRETOL CR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-02 | 2017-12-13 | 27924 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2022-01-12 | 2022-03-04 | 152535 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2024-01-15 | 2024-02-22 | 216049 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2024-08-27 | 2024-11-26 | 235981 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-06-23 | 2017-07-11 | 13861 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-07-27 | 2017-09-13 | 17414 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-09-18 | 2017-11-02 | 22359 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Actual shortage | 2025-04-28 | 2025-04-29 | 255935 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2017-09-05 | 2017-09-14 | 20969 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
| VOLTAREN SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-04-02 | 2019-09-11 | 80298 |
| VOLTAREN | 100MG | SUPPOSITORY | Discontinued | 2017-05-01 | 2017-11-02 | 8504 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |